TrialCancer chemotherapy and pharmacology2021

Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).

Keiichiro Ishibashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.